vcvibes

Aphelion Cardeation

Emerging manager

Built from this firm's Form D filings. The firm files no SEC adviser report.

HQ
CO

Aphelion Capital is a healthcare venture capital firm. It invests in capital efficient products and services that improve patient outcomes at the same or lower cost to the healthcare system. The team includes Ned Scheetz, Managing Partner; Chris Baker, MD, Clinical Partner; Jake Martellaro, Principal; John Kim, MD, Managing Director; Shifali Singh, PhD, Clinical Associate; Bob Mellen, Venture Partner; and Robert Thomas, Venture Partner.

New fund likely raising soon

The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.

01 · Says / Does

TagSaysDoes
StagesNot statedNot enough dated deals
SectorsDigital health, Medical devicesNot enough dated deals
RegionsNot statedNot enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

FundYearSizeStatus
Aphelion Cardeation II, LLC

Aphelion Capital is a healthcare venture firm investing in early and mid stage medical device and digital health companies. It backs capital efficient medical technologies and services that improve patient outcomes at the same or lower cost to the healthcare system. Inferred from the firm's website

2022$42.92M (Form D)Late investment period

03 · People across funds

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

  1. https://www.aphelioncapital.net
  2. https://www.aphelioncapital.net/team-1
  3. https://www.aphelioncapital.net/

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026